More weapons in the arsenal against ischemic retinopathy
- PMID: 11306596
- PMCID: PMC199562
- DOI: 10.1172/JCI12704
More weapons in the arsenal against ischemic retinopathy
Comment on
-
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.J Clin Invest. 1997 Jun 1;99(11):2625-34. doi: 10.1172/JCI119451. J Clin Invest. 1997. PMID: 9169492 Free PMC article.
-
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.J Clin Invest. 1997 Dec 15;100(12):3131-9. doi: 10.1172/JCI119868. J Clin Invest. 1997. PMID: 9399960 Free PMC article.
-
Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy.J Clin Invest. 2001 Mar;107(6):717-25. doi: 10.1172/JCI10874. J Clin Invest. 2001. PMID: 11254671 Free PMC article.
-
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy.J Clin Invest. 2001 Apr;107(8):967-74. doi: 10.1172/JCI12083. J Clin Invest. 2001. PMID: 11306600 Free PMC article.
References
-
- Smith LE, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101–111. - PubMed
-
- Michaelson IC. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK. 1948;68:137–180.
-
- Aiello LP. Vascular endothelial growth factor in ocular fluid of patients with proliferative diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources